(Health-NewsWire.Net, April 05, 2016 ) Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders.
Market analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global immunotherapy drugs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunotherapy drugs used to treat cancer, respiratory, infectious, autoimmune, and inflammatory diseases. It also considers the revenues to be generated from the sales of drugs, which are expected to be launched into the market, along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.
The market is divided into the following segments based on geography: Americas APAC EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=685210
New report, Global Immunotherapy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Company (BMS) F. Hoffmann-La Roche AG Johnson & Johnson Private Ltd. Merck & Co. Inc.
Other prominent vendors AB Science Ablynx Acorda Therapeutics ADC Therapeutics Aduro Biotech Advantagene Advaxis Agensys Inc. Agenus Inc. Alder Biopharmaceuticals AlphaVax Altor BioScience Antares Pharma Antigen Express Argos Therapeutics Inc. Astellas Pharma AstraZeneca AVAX Technologies Bavarian Nordic Baxter Bayer Biogen Biotech Pharmaceutical Biothera Boehringer Ingelheim Can-Fite BioPharma Celgene Celldex Therapeutics Celltrion Cel-Sci ChemoCentryx Chugai Pharmaceutical Coherus BioSciences CTI BioPharma CureVac Cytos Biotachnology Daiichi Sankyo Eisai Eli Lilly Fortress Biotech Galena Biopharma Genexine Genmab Gilead Sciences GSK GlobeImmune Gradalis Heat Biologics Hospira Idera Immatics ImmunoCellular Therapeutics Immunomedics ImmuPharma Immutep Incyte Inovio Pharmaceuticals Intas Pharmaceuticals Invion ISA Pharmaceuticals Janssen Biotech Juvaris Biotherapeutics KaloBios Pharmaceuticals Kyowa Hakko Kirin Lexicon Pharmaceuticals MedImmune Morphotek Neovii Biotech Northwest Biotherapeutics Novartis NovaRx Novo Nordisk OncoMed Pharmaceuticals Oncothyreon Oncovir Inc. Opexa Therapeutics Inc. Oxford BioMedica Pfizer Prima BioMed Principia Progenics Provectus Biopharmaceuticals Regeneron Sandoz Sanofi Santarus Seattle Genetics Sotio Spectrum Pharmaceuticals Takeda TG Therapeutics Transgene UbiVac UCB Vaccinex Vaccinogen Vaxon Biotech Vertex Pharmaceuticals Vical Vitae Pharmaceuticals XBiotech
Market driver Growing prevalence of cancer and autoimmune diseases For a full, detailed list, view our report
Market challenge Patent expiries of top-selling drugs For a full, detailed list, view our report
Market trend Increase in awareness programs For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Browse Detail Report With TOC @ http://www.researchmoz.us/global-immunotherapy-drugs-2016-2020-report.html
Table Of Content
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings Assumptions PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Overview: Immunotherapy Types of immunotherapy Key events Reimbursement policies Orphan drug designation and regulatory approvals PART 06: Pipeline portfolio Anticipated number of immuno-oncology pipeline assets with single and multiple indications by 2020 PART 07: Market landscape Market overview Market size and forecast Five forces analysis PART 08: Market segmentation by type of immunotherapy mAbs Immune checkpoint inhibitors Vaccines Non-specific immunotherapies PART 09: Market segmentation by therapy area PART 10: Geographical segmentation Global immunotherapy drugs market by geographical segmentation 2015-2020 Immunotherapy drugs market in Americas Immunotherapy drugs market in EMEA Immunotherapy drugs market in APAC PART 11: Market drivers Growing prevalence of cancer and autoimmune diseases Rise in older population Increase in demand for mAbs Patient assistance programs Promising pipeline PART 12: Impact of drivers PART 13: Market challenges Patent expiries of top-selling drugs High costs of biologicals Poor diagnosis and screening Adverse effects Stringent regulations PART 14: Impact of drivers and challenges PART 15: Market trends Increase in awareness programs Emergence of targeted and combination therapies Emergence of biosimilars Strategic alliances Expected entry of novel vaccines PART 16: Vendor landscape Competitive scenario Market share analysis 2015 F. Hoffmann-La Roche AbbVie Johnson & Johnson Merck Amgen BMS Other prominent vendors PART 17: Appendix List of abbreviations
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=685210
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
|